Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2010 Apr;12(2):285-96.
doi: 10.1007/s12028-009-9306-9.

Statins in the management of patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis

Affiliations
Meta-Analysis

Statins in the management of patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis

Andreas H Kramer et al. Neurocrit Care. 2010 Apr.

Abstract

Background: Delayed ischemic neurological deficits (DINDs) contribute to morbidity and mortality following aneurysmal subarachnoid hemorrhage (SAH). Based on promising preliminary reports, some clinicians routinely administer statins to prevent DINDs.

Methods: Without language restriction, we searched MEDLINE, EMBASE, the Cochrane Central Register, references of review articles, proceedings of the International Stroke Conference, and gray literature sources. Studies were selected if they compared outcomes between statin-treated and untreated patients during the 2 weeks following SAH. Data were extracted and appraised independently and in duplicate, using standardized forms. Fixed or random effects models, as appropriate based on the degree of study heterogeneity, were applied to calculate summary measures.

Results: Four RCTs, two "pseudo" RCTs, five cohort studies, and one case-control study met eligibility criteria. In the RCTs, which enrolled a total of 309 patients, statins were found to significantly reduce the occurrence of DINDs [OR 0.38 (0.23-0.65); P < 0.001], but not mortality [OR 0.51 (0.25-1.02); P = 0.06] or poor neurological recovery [OR 0.81 (0.49-1.32); P = 0.39]. Observational studies assessed 1,542 patients, of whom 385 received statins. Statin-use was not associated with any reduction in DINDs [OR 0.96 (0.71-1.31); P = 0.80], mortality [OR 1.16 (0.78-1.73); P = 0.47] or poor neurological recovery [OR 1.20 (0.84-1.72); P = 0.31]. When the results of all studies were combined, statins had no statistically significant effect.

Conclusions: Existing RCTs suggest that statins reduce DINDs, with a possible trend toward lower mortality. These findings are not supported by observational research. Although not assessed in all studies, current data do not indicate that statins improve neurological outcomes.

PubMed Disclaimer

References

    1. Stroke. 2005 Sep;36(9):2024-6 - PubMed
    1. Stat Med. 2002 Jun 15;21(11):1539-58 - PubMed
    1. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD000277 - PubMed
    1. Ann Intern Med. 2009 Aug 18;151(4):W65-94 - PubMed
    1. JAMA. 1995 Feb 1;273(5):408-12 - PubMed

MeSH terms

Substances

LinkOut - more resources